Thackray Helen M. Insider Trades

Insider Trading History

Track insider trading activity for Thackray Helen M.. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Biocryst Pharmaceuticals
Biocryst Pharmaceuticals BCRX
Chief R&d Officer
Holding Value $3.51M 377,318 shares
Last Trade
Mar 31, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$56.4k 7,525 shares
$7.50
$9.31
Biocryst Pharmaceuticals
Biocryst Pharmaceuticals BCRX
Chief R&d Officer
Holding Value $3.64M 390,939 shares
Last Trade
Dec 19, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.93M 260,950 shares
$7.39
$9.31
Biocryst Pharmaceuticals
Biocryst Pharmaceuticals BCRX
Chief R&d Officer
Holding Value $3.58M 384,843 shares
Last Trade
Dec 19, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$45k 6,096 shares
$7.39
$9.31
Biocryst Pharmaceuticals
Biocryst Pharmaceuticals BCRX
Chief R&d Officer
Holding Value $2.47M 264,989 shares
Last Trade
Dec 14, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$53.8k 7,150 shares
$7.53
$9.31
Biocryst Pharmaceuticals
Biocryst Pharmaceuticals BCRX
Chief R&d Officer
Holding Value $2.53M 272,139 shares
Last Trade
May 14, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$176k 30,000 shares
$5.86
$9.31
Biocryst Pharmaceuticals
Biocryst Pharmaceuticals BCRX
Chief R&d Officer
Holding Value $2.25M 242,139 shares
Last Trade
Mar 31, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$38.2k 7,525 shares
$5.08
$9.31
Immunogen
Immunogen IMGN
Director
Holding Value $0 0 shares
Last Trade
Feb 12, 2024 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$4.77M 152,759 shares
$31.24
$31.24
Immunogen
Immunogen IMGN
Director
Holding Value $96k 3,074 shares
Last Trade
Dec 29, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$7.47k 252 shares
$29.65
$31.24
Biocryst Pharmaceuticals
Biocryst Pharmaceuticals BCRX
Chief R&d Officer
Holding Value $2.32M 249,664 shares
Last Trade
Dec 19, 2023 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$33.8k 5,580 shares
$6.05
$9.31
Biocryst Pharmaceuticals
Biocryst Pharmaceuticals BCRX
Chief R&d Officer
Holding Value $2.38M 255,244 shares
Last Trade
Dec 14, 2023 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$19.5k 3,031 shares
$6.43
$9.31
Biocryst Pharmaceuticals
Biocryst Pharmaceuticals BCRX
Chief R&d Officer
Holding Value $2.4M 258,275 shares
Last Trade
Dec 14, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.53M 238,000 shares
$6.43
$9.31
Immunogen
Immunogen IMGN
Director
Holding Value $88.1k 2,822 shares
Last Trade
Sep 29, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$7.49k 472 shares
$15.87
$31.24
Immunogen
Immunogen IMGN
Director
Holding Value $73.4k 2,350 shares
Last Trade
Jun 30, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$7.49k 397 shares
$18.87
$31.24
Immunogen
Immunogen IMGN
Director
Holding Value $612k 19,597 shares
Last Trade
Jun 14, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$579k 32,687 shares
$17.72
$31.24
Biocryst Pharmaceuticals
Biocryst Pharmaceuticals BCRX
Chief R&d Officer
Holding Value $1.93M 207,275 shares
Last Trade
Apr 03, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$58k 7,000 shares
$8.29
$9.31
Immunogen
Immunogen IMGN
Holding Value $61k 1,953 shares
Last Trade
Mar 31, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$7.5k 1,953 shares
$3.84
$31.24
Biocryst Pharmaceuticals
Biocryst Pharmaceuticals BCRX
Chief R&d Officer
Holding Value $1.24M 133,275 shares
Last Trade
Dec 15, 2022 Sale (Open Market)Shares sold on the open market or in a private sale.
$34k 3,125 shares
$10.89
$9.31
Immunogen
Immunogen IMGN
Director
Holding Value $1M 32,066 shares
Last Trade
Jun 15, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$108k 32,066 shares
$3.37
$31.24
Biocryst Pharmaceuticals
Biocryst Pharmaceuticals BCRX
Chief R&d Officer
Holding Value $1.27M 136,400 shares
Last Trade
Apr 01, 2022 Sale (Open Market)Shares sold on the open market or in a private sale.
$123k 7,600 shares
$16.20
$9.31
Biocryst Pharmaceuticals
Biocryst Pharmaceuticals BCRX
Chief R&d Officer
Holding Value $1.91M 205,000 shares
Last Trade
Dec 14, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.85M 249,000 shares
$11.43
$9.31

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up